August 27, 2025

Robots reshape surgical services, part 1: Emerging tech, rising risks

By: Cynthia Saver
Share

Takeaways

• Robot-assisted surgery (RAS) is now an option in many specialties and for adult and pediatric patients; RAS-related ethical issues include access and patient privacy.

• Intuitive Surgical continues to dominate the marketplace, but many companies are working on expanding their range of options.

• Some current trends and future developments for RAS are AI, enhanced imaging, and telesurgery.


Katie Kentner, MSN, RN, NE-BC, CNOR

When Katie Kentner, MSN, RN, NE-BC, CNOR, arrived for work one Wednesday in June 2012, she had no idea how much her world was about to shift. Her hospital had just purchased a surgical robot—scheduled to arrive that Friday—and only one surgeon was familiar with the new tool. Staff and anesthesia providers would face a steep learning curve. “It was quite a challenge,” she recalls.

By October, the hospital had completed its first successful case, and Kentner has not looked back. Now a director of perioperative services at Vanderbilt University Medical Center in Nashville, she is part of a robust robot-assisted surgery (RAS) program. The robots have come a long way, too, she says, pointing specifically to faster, easier setup (sidebar, OR workflow evolves).

Other advances, including greater image clarity, new instrumentation, and the advent of single-port models, have spurred the expansion of robots into multiple specialties and their use in both pediatric and adult patients (sidebar, Specialties using robot-assisted surgery).

This has been the case at Johns Hopkins in Baltimore. Beyond performing about 2,700 thoracic and abdominal RASs annually at its main campus, they have expanded the use of robotics into many other specialties. “We’ve been growing [our RAS program] by about 8% to 12% annually over the past couple of years,” says John Doerr, BSN, robotic surgery program manager. “We’re experiencing incremental improvements in technology, and surgeons are branching out to find newer uses for some of these platforms to assist their patients in new and exciting ways.”

Read on to learn about advancing technology and expanding use cases, as well as an overview of the RAS market and what experts had to say about the legal and ethical considerations. Part two, scheduled for OR Manager’s November/December issue, will explore strategies for establishing and sustaining a successful RAS program.

 

Weighing RAS value proposition

Benefits of RAS include shorter operating times and patient lengths of stay. For example, a 2023 report from ECRI on the use of the da Vinci system in colorectal and gynecologic surgery noted it may reduce hospital length of stay compared to laparoscopic and open colon/open rectal procedures. It also may reduce hospital length of stay compared with open gynecologic surgery.

Andrew Hung, MD

“It’s a minimally invasive procedure, so there’s a smaller incision and quicker wound healing and recovery time,” explains Andrew Hung, MD, a urologist based at Cedars-Sinai Medical Center in Los Angeles who specializes in robotic surgery for diseases of the kidney and prostate.

RAS can benefit surgeons too. “There’s better visibility, so it’s easier to preserve structures that need to be preserved,” Dr Hung says. The robot’s instruments also can help the surgeon reach areas that are difficult to access manually, helping to improve accuracy.

However, some researchers have reported the robot offers little to no advantage over traditional minimally invasive surgery. For instance, a 2025 study by Woldehana and colleagues that included more than 840,000 adults found that robot-assisted cholecystectomy was associated with more postoperative complications, longer hospitalizations, and increased drain use compared to laparoscopic cholecystectomy, although the two had similar bile duct injury rates.

Part of the difficulty with conducting and analyzing RAS research is the degree of variability. Peter McCulloch, professor of surgery at the University of Oxford in the UK, notes testing a drug is easier than testing surgery, where the procedure can vary from one surgeon to the next, regardless of whether they use a robot. Surgeon training and case complexity also play a role in making comparisons difficult.

Dr Hung and his team at the Hung Robotics Lab are working to address some of these issues, with the goal of narrowing surgeon and patient outcome variability. “Instead of thinking of surgery as an art form, we’re trying to provide some objectivity to what’s being done and relate what’s being done to patient outcomes,” Dr Hung says. “We don’t have to make everybody a master surgeon, but we’d like to make everybody a safe surgeon.” The goal is to quantify surgery in an objective way, so variability can be reduced and minimum surgeon performance and patient outcomes can be established. This might involve identifying the optimal way to train certain surgical skills and perform certain techniques, and providing feedback to individual surgeons.

More research is needed to clearly delineate where robots provide the most benefit. ECRI notes that ongoing evaluation is important as technology evolves.

 

Expanding technology, use cases

Whatever the value proposition for any given organization, robots likely will keep booming for years to come. In 2024, the global surgical robotics market amounted to $10.9 billion, according to a 2025 report from iData Research, and it is expected to increase at a CAGR of 15.7% to hit $30.3 billion by 2031.

Several trends and technological developments are fueling continued RAS growth. These include:

Bhushan Jayeshkumar Patel, MEng, MBA

Integration. “It’s no longer just about different robot arms and cameras,” says Bhushan Jayeshkumar Patel, MEng, MBA, a surgical robot technology expert and senior member of the Institute of Electrical and Electronics Engineers (IEEE). Hospitals seek platforms that not only support surgery, but also generate real-time clinical data and operational intelligence—real-time insights that help hospitals optimize workflows and resource utilization. As he puts it, “The platform needs to integrate into a digital surgery ecosystem, which includes data analytics, AI-driven insight, and intraoperative guidance.”

For example, a surgical robotic platform that tracks instrument usage, OR turnover time, and surgeon efficiency can provide actionable data to reduce delays, improve scheduling accuracy, and identify opportunities for cost savings. “This turns the robot from just a surgical tool into a smart, data-generating asset that supports hospital operations and decision-making,” Patel says. He adds aggregate data obtained from individual robot data are stored in the cloud, “This can be used to make the robot more accurate and precise.”

AI. Dr Hung, who is editor of the book Artificial Intelligence in Urology: Present and Future, says he has not seen AI deployed in current robots. In addition to the technical demand of integrating the technology into the computer, the integration would require FDA approval. “The bar is set relatively high for that—for good reason,” he says.

But interest in incorporating AI into robots is high. “AI-powered robotic surgery is not just a trend, but a fundamental shift that aims to elevate minimally invasive procedures to new heights,” Patel wrote in an article for Forbes. Potential benefits include real-time tissue recognition, greater precision, and continuous learning—that is, the continuous refinement of AI algorithms based on data from each procedure.

AI also can enhance a surgeon’s ability to plan the surgery. “When we take a tour, we plan everything—our transportation, where we plan to stay, where we will eat, everything,” Patel says. “It can be the same with robotic surgery.” The surgeon could put all the relevant patient data for knee replacement surgery, such as age, gender, symptoms, and imaging scans, into the robot. By comparing that data with data obtained from previous surgeries, AI could assist the surgeon in developing the surgical plan and identifying possible complications.

“Companies are training AI models on vast libraries of laparoscopic footage to support surgical decision-making, for instance, by helping highlight anatomical structures or, in experimental settings, suggesting where tumor margins may lie based on prior annotated data,” Patel says. “In the near term, and certainly within a decade, AI will be the co-pilot in the OR.” However, Patel also notes the importance of regularly comparing AI-generated suggestions with patient outcomes, so that algorithms can be adjusted as needed.

Haptic feedback. One limitation of robots has been that surgeons have not been able to experience the tactile sensation they get when they use their hands, referred to as haptic feedback. “[With a robot] you can’t feel the resistance of the tissue,” Dr Hung says. However, this is changing. For example, Intuitive’s da Vinci 5 robot provides what the company calls “Force Feedback,” which gives the surgeon a better sense of the pressure being exerted on tissue.

Autonomy level. While researchers have explored automation, in practice, it only exists as cues to the surgeon or small tasks. “Like an everyday car, we’re at the stage where we have the equivalent of the lane departure warning or back-up camera to enhance safety,” Dr Hung says.

Advancements in the tasks a robot can perform autonomously, such as stapling, will likely continue. These may change how robots are approved by the FDA. In a review article, Lee and colleagues note the FDA currently regulates surgical robots as Class II (moderate risk) devices. In the future, robots with higher levels of autonomy may be deemed as Class III (high risk) devices that require premarket approval, the most stringent regulatory pathway.

Many experts question whether a robot could ever perform surgery autonomously, and most agree it will not happen in the near future. “A robot will not perform surgery by themselves anytime soon, not even in a decade,” Patel says. He adds that patients sometimes have the misconception the robot is performing surgery, so it is important to stress that the robot is assisting the surgeon.

Enhanced imaging. Technologies such as augmented reality (AR), virtual reality (VR), and high resolution 3-D imaging enhance the ability of the robot to integrate information in ways that add value for the surgeon. An example of AR is the technique of overlaying CT scan or MRI imaging over what the surgeon sees to help identify structures invisible to the naked eye. In the case of prostate cancer, such capability could enable removing cancerous tissue that might otherwise go undetected. “That could be the difference between a patient being cured of cancer or not,” Dr Hung says, but adds that much of this work is still in the research phase.

Mixed reality combines elements of AR and VR, allowing interaction between digital objects and the physical world. Benefits include enhanced visualization and precision. However, mixed reality systems are expensive, particularly when integrated into surgical robotic platforms, and must meet strict FDA requirements. “While the hardware itself, such as headsets like Microsoft HoloLens or Magic Leap, might be relatively affordable, the real cost lies in the software development, system integration, regulatory compliance, and maintenance,” Patel says.

Telesurgery. In June 2024, a surgeon in Florida performed a robot-assisted prostatectomy on a patient in Angola, Africa, as part of an FDA-approved clinical trial for transcontinental robotic telesurgery. In the US, telesurgery could enable people in rural areas to gain access to surgeons with RAS expertise without having to travel far. Ideally, robots could be deployed locally, with surgeons based elsewhere performing the surgery. “I’d like to see surgeons be able to connect to remote robots so patients can receive the same excellent quality of care wherever they live,” Doerr says. Barriers include insufficient high-speed networks in certain areas and concerns about transmission of patient data.

 

Legal, ethical issues

RAS expands the scope of potential surgical liability beyond surgeons and hospitals. Robotic manufacturers and companies providing software used in AI also may be held responsible for patient harm. More clarity is needed in this area. For example, it is often uncertain as to precisely how a system using AI makes decisions. A 2022 study by DeRavin and colleagues found malpractice claims related to RAS had increased more than 250% in the past 7 years, although malpractice litigation in RAS was infrequent. The most common claims were negligent surgery, misdiagnosis/failure to diagnose, delayed treatment, and lack of informed consent.

RAS also raises ethical issues, which are both complex and interconnected, according to Joschka Haltaufderheide, MA, a research associate for the Project Digital Medical Ethics Network at the University of Potsdam in Brandenberg, Germany. “Questions about when and under what conditions the use of RAS is appropriate can’t be answered with a single ethical principle,” he writes in an email. “They require a broad and integrated ethical analysis spanning over different fields, from medical ethics to ethics of technology and even considerations of economic ethics.”

Haltaufderheide advocates for more discussion about the ethical issues surrounding RAS because the technology is advancing so rapidly. (sidebar, Robot-assisted surgery ethics). One consideration is the concept of functional autonomy, which he defines as “the idea that machines begin to make decisions independently within defined tasks.” An analogy is the self-driving car.

Functional autonomy raises ethical questions about control and responsibility. As a robot system becomes more autonomous, older frameworks, where the robot is seen as an extension of the surgeon, are inadequate. This raises fundamental questions such as who is in control and how the surgeon-patient relationship is preserved. Haltaufderheide emphasizes these issues need to be addressed now, while the next generation of robots is in development.

Equity is another consideration. Not all hospitals can afford to purchase a robot, so patient access can be limited based on geographic location. The advance of AI also creates concerns about data bias driving care inequities—an issue the National Academy of Medicine aims to address with its 2025 AI code of conduct.

Robots require humans to do things in a specific way to work as intended, Haltaufderheide writes. “We accommodate to these technological necessities, and if we do so not by changing how the device works but by changing how ‘we work,’ we can get in trouble very quickly—if we fail to consider the implications.” For example, becoming over-reliant on technology can affect surgeons’ judgment and autonomy.

For OR managers, implications extend to team workflow, dynamics, and accountability. “It’s not just about how well the machine performs—it’s also about how well people can perform around and with the machine,” Haltaufderheide writes.

 

—Cynthia Saver, MS, RN, is owner of CLS Development, Columbia, Maryland, which provides editorial services to healthcare publications.

 

References

Benadjaoud Y, Serratos O, Mendelsohn M, et al. Exclusive look at groundbreaking remote robotic surgery: Patient was in Africa; doctor was in Florida. ABC News. June 17, 2025.

Celotto F, Ramacciotti N, Mangano A, et al. Da Vinci single-port robotic system current application and future perspective in general surgery: A scoping review. Sug Endosc. 2024;38(9):4814-4830.

Dagnino G, Kundrat D. Robot-assistive minimally invasive surgery: Trends and future directions. Int J Intelligent Robotics and Appl. 2024;8:812-826.

De Ravin E, Sell E A, Newman J G, et al. Medical malpractice in robotic surgery: A Westlaw database analysis. J Robot Surg. 2023;17(1):191-196.

Dey M. Surgical robotics statistics and facts. Electro IQ. 2025.

ECRI. The da Vinci surgical robot and the importance of iterative evidence review. 2023.

Haltaufderheide J, Pfisterer-Heise S, Pieper D, et al. The ethical landscape of robot-assisted surgery: A systematic review. J Robot Surg. 2025;19(1):102.

Kelly S. 4 robotic surgical trends to watch in 2025. MedTech Dive. 2025.

Knudsen J E, Ghaffar U, Ma R, et al. Clinical applications of artificial intelligence in robotic surgery. J Robot Surg. 2024;18(1):102.

Lee A, Baker T S, Bederson J B, et al. Levels of autonomy in FDA-cleared surgical robots: a systematic review. NPJ Digit Med. 2024;7(1):103.

MassDevice’s surgical robotics special report. MassDevice. March 4, 2025.

May M. The next generation of robotic surgery is emerging: but is it better than a human? Nat Med. 2024;30(1):2-5.

National Academy of Medicine. An artificial intelligence code of conduct for health and medicine: Essential guidance for aligned action. Washington, DC: The National Academies Press. 2025.

Patel B J. AI-powered robotic surgery: pushing the boundaries of minimally invasive procedures. Forbes. 2024.

Patel B J. Tech trends in mixed reality and robotic surgery. Forbes. 2024.

Patel B J. The future of surgical robotics: innovation and predictions. Forbes. 2024.

Power D. Ethical considerations in the era of AI, automation, and surgical robots: there are plenty of lessons from the past. Discov Artif Intell. 2024;4(65).

Reddy K, Gharde P, Tayade H, et al. Advancements in robotic surgery: A comprehensive overview of current utilizations and upcoming frontiers. Cureus. 2023;15(12):e50415.

Rojas Burbano J C, Ruiz N I, Rojas Burbano G A, et al. Robot-assisted surgery: Current applications and future trends in general surgery. Cureus. 2025;17(4):e82318.

Surgical Robotics and Navigation Market Analysis, Size, Share & Trend Analysis | Global | 2025-2031 | MedSuite | Includes: Surgical Navigation Market and Surgery Robotics Market. iData Research. February 7, 2025.

Vanderbilt University. The future of robotic surgery: 3 trends to look for. 2023.

Witharm H. Robot-assisted surgery: An analysis of the legal and economic implications. Arizona J Interdisciplinary Studies. 2022;8.

Woldehana N A, Jung A, Parker B C, et al. Clinical outcomes of laparoscopic vs robotic-assisted cholecystectomy in acute care surgery. JAMA Surg. 2025:e251291.

Yang H Y, Seon J K. The landscape of surgical robotics in orthopedics surgery. Biomed Eng Let. 2023;13(4):537-542.

Young J. AMA Code of Medical Ethics’ opinions related to robotic surgery. AMA J Ethics. 2023;25(8):605-608.

Join our community

Learn More
Video Spotlight
Live chat by BoldChat